|4Feb 24, 2:20 PM ET

IMMUNOGEN INC 4

4 · IMMUNOGEN INC · Filed Feb 24, 2014

Insider Transaction Report

Form 4
Period: 2014-02-20
Morris Charles Q
Executive VP & CDO
Transactions
  • Sale

    Common Stock

    2014-02-20$17.10/sh13,672$233,73737,500 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-02-20$11.93/sh13,672$163,107179,190 total
    Exercise: $11.93From: 2013-11-26Exp: 2022-11-26Common Stock (13,672 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-20$11.93/sh+13,672$163,10751,172 total
Footnotes (3)
  • [F1]Weighted average price of shares sold.
  • [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on August 29, 2013.
  • [F3]Exercisable as to 50,000 shares commencing on November 26, 2013, 50,000 shares commencing on November 26, 2014, 50,000 shares commencing on November 26, 2015, and 50,000 shares commencing on November 26, 2016.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -